Steepening of the slope of QT interval restitution is a risk factor for drug-induced arrhythmias

被引：0
|
作者：
Chauveau, S. [1 ]
Rahim, T. [1 ]
Jiang, Y. [1 ]
Coronel, R. [2 ]
Opthof, T. [2 ]
Janse, M. [2 ]
Anyukhovsky, Y. [1 ]
Cohen, I. S. [1 ]
Rosen, M. R. [1 ]
机构：
[1] SUNY Stony Brook, Dept Physiol & Biophys, Med Ctr, Inst Mol Cardiol, Stony Brook, NY 11794 USA
[2] Univ Amsterdam, Amsterdam, Netherlands
来源：
EUROPEAN HEART JOURNAL | 2014年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P1488
引用
收藏
页码：268 / 269
页数：2
相关论文
共 50 条
  • [21] Drug-induced QT interval prolongation: regulatory perspectives and drug development
    Shah, RR
    ANNALS OF MEDICINE, 2004, 36 : 47 - 52
  • [22] The impact of drug-induced QT interval prolongation on drug discovery and development
    Bernard Fermini
    Anthony A. Fossa
    Nature Reviews Drug Discovery, 2003, 2 : 439 - 447
  • [23] The impact of drug-induced qt interval prolongation on drug discovery and development
    Fermini, B
    Fossa, AA
    NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (06) : 439 - 447
  • [24] Strategies to reduce the risk of drug-induced QT interval prolongation: a pharmaceutical company perspective
    Pollard, C. E.
    Valentin, J-P
    Hammond, T. G.
    BRITISH JOURNAL OF PHARMACOLOGY, 2008, 154 (07) : 1538 - 1543
  • [25] Drug-Induced QT Interval Prolongation: Mechanisms, Risk Factors, Genetics and Clinical Management
    Akturk, Gozde
    Kalkan, Sule
    JOURNAL OF BASIC AND CLINICAL HEALTH SCIENCES, 2019, 3 (03): : 193 - 198
  • [26] Drug-Induced QT Interval Prolongation and Torsade De Pointes: Identification of Risk Factors
    Letsas, Konstantinos P.
    TRAKYA UNIVERSITESI TIP FAKULTESI DERGISI, 2010, 27 : 49 - 53
  • [27] Preferred QT correction formula for the assessment of drug-induced QT interval prolongation
    Chiladakis, I.
    Kalogeropoulos, A.
    Arvanitis, P.
    Koutsogiannis, N.
    Zagli, F.
    Alexopoulos, D.
    EUROPEAN HEART JOURNAL, 2010, 31 : 266 - 266
  • [28] Preferred QT Correction Formula for the Assessment of Drug-Induced QT Interval Prolongation
    Chiladakis, John
    Kalogeropoulos, Andreas
    Arvanitis, Panagiotis
    Koutsogiannis, Nikolaos
    Zagli, Fani
    Alexopoulos, Dimitrios
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2010, 21 (08) : 905 - 913
  • [29] Risk assessment of drug-induced QT prolongation
    Isbister, Geoffrey K.
    AUSTRALIAN PRESCRIBER, 2015, 38 (01) : 20 - 24
  • [30] An update on risk factors for drug-induced arrhythmias
    Vlachos, Konstantinos
    Georgopoulos, Stamatis
    Efremidis, Michael
    Sideris, Antonios
    Letsas, Konstantinos P.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2016, 9 (01) : 117 - 127
12345